✦ LIBER ✦

High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients

✍ Scribed by Lee, Soo Hyeon; Chang, Myung Hee; Baek, Kyung Kee; Han, Boram; Lim, Taekyu; Lee, Jeeyun; Park, Joon Oh

Book ID: 120232901
Publisher: S. Karger AG
Year: 2011
Tongue: English
Weight: 201 KB
Volume: 80
Category: Article
ISSN: 0030-2414
DOI: 10.1159/000328795

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of randomised studies of the EOR

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients

✍ A.T van Oosterom; H.T Mouridsen; O.S Nielsen; P Dombernowsky; K Krzemieniecki; I 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Dose-intensive first-line chemotherapy w

Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study

✍ R Palumbo; C Neumaier; M Cosso; G Bertero; P Raffo; N Spadini; S Valente; G Vill 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 93 KB

High-dose chemotherapy and autologous pe

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma

✍ M. Engelhardt; R. Zeiser; G. Ihorst; J. Finke; C. I. Müller 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 512 KB

Brostallicin versus doxorubicin as first

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

✍ Gelderblom, H.; Blay, J.Y.; Seddon, B.M.; Leahy, M.; Ray-Coquard, I.; Sleijfer, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 758 KB

Dose-intensive chemotherapy with growth

Dose-intensive chemotherapy with growth factor or autologous bone marrow/stem cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma : A systematic review

✍ Shailendra Verma; Jawaid Younus; Denise Stys-Norman; Adam E. Haynes; Martin Blac 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

## Abstract A systematic review was performed to determine whether first‐line dose‐intensive chemotherapy supported by growth factor or autologous bone marrow/stem cell transplantation improves response rate, time‐to‐disease progression, or survival compared with standard‐dose chemotherapy in patie